E2022 Patch Formulation Multiple Dose Phase I Study
Phase of Trial: Phase I
Latest Information Update: 30 May 2012
At a glance
- Drugs Donepezil; Donepezil
- Indications Alzheimer's disease; Aphasia; Attention deficit and disruptive behaviour disorders; Dementia; Migraine; Mild cognitive impairment; Vascular dementia
- Focus Pharmacokinetics
- 30 May 2012 Actual end date (Feb 2012) added as reported by ClinicalTrials.gov.
- 30 May 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Oct 2011 New trial record